Endometrial Cancer Characteristics and Risk of Recurrence Endometrial Cancer Characteristics and Risk of Recurrence
This study describes the clinicopathologic characteristics and survival outcomes of endometrial adenocarcinomas stratified by mismatch repair status.American Journal of Clinical Pathology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - February 4, 2022 Category: Consumer Health News Tags: Pathology & Lab Medicine Journal Article Source Type: news
Lenvatinib + Pembrolizumab Treats Advanced Endometrial Cancer
MONDAY, Jan. 31, 2022 -- For patients with advanced endometrial cancer, lenvatinib plus pembrolizumab results in significantly longer progression-free and overall survival than the physician ' s choice of chemotherapy, according to a study published... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 31, 2022 Category: Pharmaceuticals Source Type: news
Higher Coffee Consumption Tied to Lower Risk for Endometrial Cancer
Caffeinated coffee tied to even lower risk than decaffeinated, with no differences seen by brewing method (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - January 29, 2022 Category: Cancer & Oncology Tags: Family Medicine, Gynecology, Internal Medicine, Oncology, Journal, Source Type: news
Higher Coffee Consumption Tied to Lower Risk for Endometrial Cancer
FRIDAY, Jan. 28, 2022 -- Increased coffee intake is associated with a lower risk for endometrial cancer (EC), according to a meta-analysis published online Jan. 19 in the Journal of Obstetrics and Gynaecology Research.
Yu Gao, from the Liangxiang... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 28, 2022 Category: Pharmaceuticals Source Type: news
What Are Common Gastrointestinal Polyposes in Children?
Discussion
Bloody stools or blood in the diaper is a relatively common complaint in general pediatrics. For most patients it is often a minor concern. Commonly it is a transient problem (e.g. rectal fissure caused by constipation or trauma) or often not blood (e.g. urate crystals in the diaper, food, menses, etc.). Real blood does occur with an identifiable cause such as long distance running or heavy exercise, or milk protein allergy/sensitivity that improves with a milk-restricted diet. Many more serious causes are associated with heavier or more recalcitrant bleeding, increased defecation, abdominal pain, poor eating an...
Source: PediatricEducation.org - January 24, 2022 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news
Immune - Based Drug Fights Advanced Endometrial Cancer: Study
(Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - January 13, 2022 Category: Cancer & Oncology Tags: Gynecology, Nursing, Oncology, Pharmacy, Research, News, Source Type: news
Immune-Based Drug Fights Advanced Endometrial Cancer: Study
Title: Immune-Based Drug Fights Advanced Endometrial Cancer: StudyCategory: Health NewsCreated: 1/13/2022 12:00:00 AMLast Editorial Review: 1/13/2022 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - January 13, 2022 Category: Cancer & Oncology Source Type: news
F-18 fluoroestradiol tracer useful for diagnosing breast cancer
F-18 fluoroestradiol PET/CT imaging could improve patient management in wome...Read more on AuntMinnie.comRelated Reading:
PET aids in treatment of metastatic breast cancer patients
SNMMI, Zionexa call out CMS for reimbursement error
FES-PET could predict endometrial cancer outcomes
FES-PET enhances treatment for metastatic breast cancer (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - November 28, 2021 Category: Radiology Source Type: news
Why Black Women Are More Likely to Die of Endometrial Cancer Why Black Women Are More Likely to Die of Endometrial Cancer
In this Q&A, Kemi Doll, MD, MSCR, details her research journey to understand this major disparity and how to fix itMedscape Oncology (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - October 13, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology Commentary Source Type: news
Science Saturday: Uterine microbe found to have disease-causing behavior in endometrial cancer
A tiny microbe thriving in the uterine microbiome — a population of bacteria, viruses, yeasts/fungi in and around the uterus— could be a contributing driver of endometrial cancer, according to a new Mayo Clinic study. "We have found that a microbe that is particularly associated with endometrial cancer is capable of pathogenic behavior, and is stimulated by one of the main risk factors for the disease — estrogen exposure," explains Marina Walther-Antonio, Ph.D., a researcher within the Mayo… (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - September 4, 2021 Category: Databases & Libraries Source Type: news
Roche receives FDA approval for first companion diagnostic to identify dMMR solid tumour patients eligible for anti-PD-1 immunotherapy
Basel, 18 August 2021 – Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced U.S. Food and Drug Administration (FDA) approval of the VENTANA MMR RxDx Panel, advancing the company ' s commitment to personalised healthcare through tests that determine which patients are most likely to benefit from specific and targeted therapies. The VENTANA MMR RxDx Panel is the first companion diagnostic test to aid in identifying patients whose solid tumours are deficient in DNA mismatch repair (MMR), who may be eligible for JEMPERLI (dostarlimab-gxly) monotherapy, an anti-PD-1 immunotherapy from GSK. The test evaluates a panel of MMR pro...
Source: Roche Investor Update - August 18, 2021 Category: Pharmaceuticals Source Type: news
Roche receives FDA approval for first companion diagnostic to identify dMMR solid tumour patients eligible for anti-PD-1 immunotherapy
Basel, 18 August 2021 – Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced U.S. Food and Drug Administration (FDA) approval of the VENTANA MMR RxDx Panel, advancing the company ' s commitment to personalised healthcare through tests that determine which patients are most likely to benefit from specific and targeted therapies. The VENTANA MMR RxDx Panel is the first companion diagnostic test to aid in identifying patients whose solid tumours are deficient in DNA mismatch repair (MMR), who may be eligible for JEMPERLI (dostarlimab-gxly) monotherapy, an anti-PD-1 immunotherapy from GSK. The test evaluates a panel of MMR pro...
Source: Roche Media News - August 18, 2021 Category: Pharmaceuticals Source Type: news
FDA grants regular approval to pembrolizumab and lenvatinib for advanced endometrial carcinoma
- Oncology - Cancer (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - July 27, 2021 Category: Drugs & Pharmacology Authors: FDA Source Type: news
Recommended TVUS Screening Thresholds May Miss Endometrial Cancer in Black Women
Current criteria for noninvasive transvaginal ultrasound used to determine the need for endometrial biopsy not as accurate in Black women (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - July 23, 2021 Category: Cancer & Oncology Tags: Family Medicine, Gynecology, Internal Medicine, Oncology, Radiology, Journal, Source Type: news
Recommended TVUS Screening Thresholds May Miss Endometrial Cancer in Black Women
FRIDAY, July 23, 2021 -- Adherence to current clinical guidelines for the evaluation of postmenopausal bleeding may result in systematic underdiagnosis of endometrial cancer (EC) in Black women, according to a study published online July 15 in JAMA... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 23, 2021 Category: Pharmaceuticals Source Type: news
